Flagstar Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
3,906
-16
| -0.4% | -$2.58K | 0.17% | 106 |
|
|
2025
Q1 | $667K | Sell |
3,922
-67
| -2% | -$11.4K | 0.17% | 115 |
|
|
2024
Q4 | $663K | Buy |
3,989
+36
| +0.9% | +$5.98K | 0.17% | 109 |
|
|
2024
Q3 | $680K | Hold |
3,953
| – | – | 0.17% | 109 |
|
|
2024
Q2 | $609K | Sell |
3,953
-47
| -1% | -$7.24K | 0.17% | 112 |
|
|
2024
Q1 | $615K | Buy |
4,000
+151
| +4% | +$23.2K | 0.17% | 108 |
|
|
2023
Q4 | $608K | Buy |
3,849
+53
| +1% | +$8.38K | 0.19% | 105 |
|
|
2023
Q3 | $556K | Buy |
3,796
+313
| +9% | +$45.8K | 0.21% | 96 |
|
|
2023
Q2 | $533K | Sell |
3,483
-502
| -13% | -$76.9K | 0.2% | 97 |
|
|
2023
Q1 | $618K | Sell |
3,985
-28
| -0.7% | -$4.34K | 0.22% | 91 |
|
|
2022
Q4 | $619K | Sell |
4,013
-98
| -2% | -$15.1K | 0.22% | 93 |
|
|
2022
Q3 | $543K | Buy |
4,111
+1,060
| +35% | +$140K | 0.2% | 100 |
|
|
2022
Q2 | $413K | Buy |
3,051
+1,282
| +72% | +$174K | 0.15% | 110 |
|
|
2022
Q1 | $263K | Buy |
+1,769
| New | +$263K | 0.08% | 135 |
|
|
2021
Q4 | – | Sell |
-750
| Closed | -$125K | – | 154 |
|
|
2021
Q3 | $125K | Buy |
+750
| New | +$125K | 0.04% | 137 |
|